Buprenorphine Group Medical Visits in Primary Care

PHASE3CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions
Opioid-Related Disorders
Interventions
BEHAVIORAL

G-BMT

The G-BMT intervention will include weekly group visits (for 8 weeks) where 5-10 patients simultaneously receive care from a multidisciplinary team of a generalist physician and a behavioral specialist. Group visits will last 90 minutes and include: BMT education, instruction on self-management skills, peer support, and individual medical management.

BEHAVIORAL

Treatment as usual

Primary care physicians who prescribe buprenorphine will be trained to follow a protocol of BMT intensification, which includes increased visit frequency, referral for mental health counseling, and referral to addiction treatment specialist.

DRUG

Buprenorphine

All participants will continue to receive maintenance treatment with buprenorphine-naloxone

Trial Locations (1)

10451

Comprehensive Health Care Center, The Bronx

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Montefiore Medical Center

OTHER

NCT02526212 - Buprenorphine Group Medical Visits in Primary Care | Biotech Hunter | Biotech Hunter